|
1
|
Benov L: Photodynamic therapy: Current
status and future directions. Med Princ Pract. 24 (Suppl 1):14–28.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braathen LR, Morton CA, Basset-Seguin N,
Bissonnette R, Gerritsen MJ, Gilaberte Y, Calzavara-Pinton P,
Sidoroff A, Wulf HC and Szeimies RM; International Society for
Photodynamic Therapy in Dermatology, : Photodynamic therapy for
skin field cancerization: An international consensus. J Eur Acad
Dermatol Venereol. 26:1063–1066. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matei C, Tampa M, Caruntu C, Ion RM,
Georgescu SR, Dumitrascu GR, Constantin C and Neagu M: Protein
microarray for complex apoptosis monitoring of dysplastic oral
keratinocytes in experimental photodynamic therapy. Biol Res.
47:332014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paszko E, Ehrhardt C, Senge MO, Kelleher
DP and Reynolds JV: Nanodrug applications in photodynamic therapy.
Photodiagn Photodyn Ther. 8:14–29. 2011. View Article : Google Scholar
|
|
5
|
Goldsmith LA, Katz SI, Gilchrest BA,
Paller AS, Leffell DJ and Wolff K: Epidermal and appendageal
tumors. Fitzpatrick's Dermatology in General Medicine. 8th.
McGrawHill; New York: pp. 1007–1094. 2012
|
|
6
|
Quinn AG and Perkins W: Non-melanoma skin
cancer and other epidermal skin tumours. Rook's Textbook of
Dermatology. 8th. Wiley Blackwell; UK: pp. 52–53. 2010
|
|
7
|
Soyer HP, Rigel DS and Wurm EMT: Actinic
keratosis, basal cell carcinoma and squamous cell carcinoma.
Dermatology. 3rd. Elsevier; Philadelphia: pp. 1773–1793. 2012
|
|
8
|
Sterry W and Stockfleth E: Malignant
epithelial tumors: In: Braun-Falco's Dermatology. 3rd.
Springer-Verlag; Berlin, Heidelberg: pp. 1357–1376. 2009
|
|
9
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tampa M, Caruntu C, Mitran M, Mitran C,
Sarbu I, Rusu LC, Matei C, Constantin C, Neagu M and Georgescu SR:
Markers of oral lichen planus malignant transformation. Dis
Markers. 2018:19595062018.doi: 10.1155/2018/1959506. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Georgescu SR, Sârbu MI, Matei C, Ilie MA,
Caruntu C, Constantin C, Neagu M and Tampa M: Capsaicin: Friend or
foe in skin cancer and other related malignancies? Nutrients.
9:13652017. View Article : Google Scholar
|
|
12
|
Costescu M, Coman OA, Tampa M, Tudose I,
Coman L and Georgescu SR: Axillary basal cell carcinoma - a rare
form of a frequent kind of carcinoma. Rom J Morphol Embryol. 54
(Suppl):851–856. 2013.PubMed/NCBI
|
|
13
|
Ene (Nicolae) CD: Nicolae I, Musetescu A,
Tampa M, Matei C and Georgescu SR: Exposure to heavy metals in
plastics industry and dyes-risk factor in the development of skin
cancer. Mater Plast. 51:180–184. 2014.
|
|
14
|
Georgescu SR, Ene CD, Nicolae IL, Mitran
M, Musetescu A, Matei C, Rusu LC and Tampa M: Reflectometric
analysis for identification of various pathological conditions
associated with lichen planus. Rev Chim. 68:1103–1108. 2017.
|
|
15
|
Caruntu C, Mirica A, Roca AE, Mirica R,
Caruntu A, Tampa M, Matei C, Constantin C, Neagu M, Badarau A, et
al: The role of estrogens and estrogen receptors in melanoma
development and progression. Acta Endocrinol (Copenh). 12:234–241.
2016.
|
|
16
|
Matei C, Tampa M, Poteca T, Panea-Paunica
G, Georgescu SR, Ion RM, Popescu SM and Giurcaneanu C: Photodynamic
therapy in the treatment of basal cell carcinoma. J Med Life.
6:50–54. 2013.PubMed/NCBI
|
|
17
|
Shibu ES, Hamada M, Murase N and Biju V:
Nanomaterials formulations for photothermal and photodynamic
therapy of cancer. J Photochem Photobiol Photochem Rev. 15:53–72.
2013. View Article : Google Scholar
|
|
18
|
Chitgupi U, Qin Y and Lovell JF: Targeted
nanomaterials for phototherapy. Nanotheranostics. 1:38–58. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park CK, Kim YH, Hwangbo S and Cho H:
Photodynamic therapy by conjugation of cell-penetrating peptide
with fluorochrome. Int J Nanomed. 12:8185–8196. 2017. View Article : Google Scholar
|
|
20
|
Nicolae I, Ene CD, Georgescu SR, Tampa M,
Matei C and Ceausu E: Effects of UV radiation and oxidative DNA
adduct 8-hydroxy-2′-deoxyguanosine on the skin diseases. Rev
Chim-Bucharest. 65:1036–1041. 2014.
|
|
21
|
Rkein AM and Ozog DM: Photodynamic
therapy. Dermatol Clin. 32:415–425. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sârbu MI, Georgescu SR, Tampa M, Sârbu AE
and Simionescu O: Biological therapies in psoriasis - revisited.
Rom J Intern Med. 56:75–84. 2018.PubMed/NCBI
|
|
23
|
Denis TG and Hamblin MR: History and
fundamentals of photodynamic therapy. In: Handbook of
Photomedicine. 1st. CRC Press; Boca Raton, USA: pp. 35–42. 2014
|
|
24
|
Raab O: On the effect of fluorescent
substances on infusoria. Z Biol. 39:5241900.
|
|
25
|
Hönigsmann H: History of phototherapy in
dermatology. Photochem Photobiol Sci. 12:16–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kou J, Dou D and Yang L: Porphyrin
photosensitizers in photodynamic therapy and its applications.
Oncotarget. 8:81591–81603. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gøtzsche PC: Niels Finsen's treatment for
lupus vulgaris. J R Soc Med. 104:41–42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lipson RL and Baldes EJ: The photodynamic
properties of a particular hematoporphyrin derivative. Arch
Dermatol. 82:508–516. 1960. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dougherty TJ: Photodynamic therapy (PDT)
of malignant tumors. Crit Rev Oncol Hematol. 2:83–116. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morton CA, Szeimies RM, Sidoroff A and
Braathen LR: European guidelines for topical photodynamic therapy
part 1: Treatment delivery and current indications - actinic
keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad
Dermatol Venereol. 27:536–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Agostinis P, Berg K, Cengel KA, Foster TH,
Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel
D, et al: Photodynamic therapy of cancer: An update. CA Cancer J
Clin. 61:250–281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tampa M, Matei CL, Popescu SA, Georgescu
SR, Neagu MO, Constantin C and Ion RM: Zinc trisulphonated
phthalocyanine used in photodynamic therapy of dysplastic oral
keratinocytes. Rev Chim. 64:639–645. 2013.
|
|
33
|
Matei C, Tampa M, Ion RM, Neagu M and
Constantin C: Photodynamic properties of aluminium sulphonated
phthalocyanines in human displazic oral keratinocytes experimental
model. Dig J Nanomater Biostruct. 7:1535–1547. 2012.
|
|
34
|
Neagu M, Constantin C, Tampa M, Matei C,
Lupu A, Manole E, Ion RM, Fenga C and Tsatsakis AM: Toxicological
and efficacy assessment of post-transition metal (Indium)
phthalocyanine for photodynamic therapy in neuroblastoma.
Oncotarget. 7:69718–69732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neagu M, Manda G, Constantin C, Radu E and
Ion RM: Synthetic porphyrins in experimental photodynamic therapy
induce a different antitumoral effect. J Porphyr Phthalocyanines.
11:58–65. 2007. View Article : Google Scholar
|
|
36
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013. View Article : Google Scholar
|
|
37
|
Caruntu C, Boda D, Dumitrascu G,
Constantin C and Neagu M: Proteomics focusing on immune markers in
psoriatic arthritis. Biomarkers Med. 9:513–528. 2015. View Article : Google Scholar
|
|
38
|
Derycke AS and de Witte PA: Liposomes for
photodynamic therapy. Adv Drug Deliv Rev. 56:17–30. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li B, Moriyama EH, Li F, Jarvi MT, Allen C
and Wilson BC: Diblock copolymer micelles deliver hydrophobic
protoporphyrin IX for photodynamic therapy. Photochem Photobiol.
83:1505–1512. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang GD, Harada A, Nishiyama N, Jiang DL,
Koyama H, Aida T and Kataoka K: Polyion complex micelles entrapping
cationic dendrimer porphyrin: Effective photosensitizer for
photodynamic therapy of cancer. J Control Release. 93:141–150.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hone DC, Walker PI, Evans-Gowing R,
FitzGerald S, Beeby A, Chambrier I, Cook MJ and Russell DA:
Generation of cytotoxic singlet oxygen via
phthalocyanine-stabilized gold nanoparticles: A potential delivery
vehicle for photodynamic therapy. Langmuir. 18:2985–2987. 2002.
View Article : Google Scholar
|
|
42
|
Wieder ME, Hone DC, Cook MJ, Handsley MM,
Gavrilovic J and Russell DA: Intracellular photodynamic therapy
with photosensitizer-nanoparticle conjugates: Cancer therapy using
a ‘Trojan horse’. Photochem Photobiol Sci. 5:727–734. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Haimov E, Weitman H, Polani S, Schori H,
Zitoun D and Shefi O: meso-Tetrahydroxyphenylchlorin-conjugated
gold nanoparticles as a tool to improve photodynamic therapy. ACS
Appl Mater Interfaces. 10:2319–2327. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Brezániová I, Záruba K, Králová J, Sinica
A, Adámková H, Ulbrich P, Poučková P, Hrubý M, Štěpánek P and Král
V: Silica-based nanoparticles are efficient delivery system for
temoporfin. Photodiagn Photodyn Ther. 21:275–284. 2018. View Article : Google Scholar
|
|
45
|
Chen G, Jaskula-Sztul R, Esquibel CR, Lou
I, Zheng Q, Dammalapati A, Harrison A, Eliceiri KW, Tang W, Chen H,
et al: Neuroendocrine tumor-targeted upconversion
nanoparticle-based micelles for simultaneous NIR-controlled
combination chemotherapy and photodynamic therapy, and fluorescence
imaging. Adv Funct Mater. 27:16046712017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Luo Y, Wu H, Feng C, Xiao K, Yang X, Liu
Q, Lin TY, Zhang H, Walton JH, Ajena Y, et al: ‘One-Pot’
fabrication of highly versatile and biocompatible poly(vinyl
alcohol)-porphyrin-based nanotheranostics. Theranostics.
7:3901–3914. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Engin AB, Nikitovic D, Neagu M,
Henrich-Noack P, Docea AO, Shtilman MI, Golokhvast K and Tsatsakis
AM: Mechanistic understanding of nanoparticles' interactions with
extracellular matrix: The cell and immune system. Part Fibre
Toxicol. 14:222017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Neagu M and Boda D: Transcriptomics in
cancer-stages toward patents in biomarkers? Recent Pat Biomark.
2:75–82. 2012. View Article : Google Scholar
|
|
49
|
Tampa M, Matei C, Caruntu C, Poteca T,
Mihaila D, Paunescu C, Pitigoi G, Georgescu SR, Constantin C and
Neagu M: Cellular impedance measurement - novel method for in vitro
investigation of drug efficacy. Farmacia. 64:430–434. 2016.
|
|
50
|
Wang M, Abbineni G, Clevenger A, Mao C and
Xu S: Upconversion nanoparticles: Synthesis, surface modification
and biological applications. Nanomedicine (Lond). 7:710–729. 2011.
View Article : Google Scholar
|
|
51
|
Zhang L, Zeng L, Pan Y, Luo S, Ren W, Gong
A, Ma X, Liang H, Lu G and Wu A: Inorganic photosensitizer coupled
Gd-based upconversion luminescent nanocomposites for in vivo
magnetic resonance imaging and near-infrared-responsive
photodynamic therapy in cancers. Biomaterials. 44:82–90. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sterry W, Paus R, Burgdorf W and
Holtermann H: Carcinoma in situ: In: Thieme Clinical Companions
Dermatology. Stuttgart, New York: pp. 417–419. 2006
|
|
53
|
Hofbauer G, Anliker M, Boehncke WH, Brand
C, Braun R, Gaide O, Hafner J, Hunger R, Itin P, Kaeuper G, et al:
Swiss clinical practice guidelines on field cancerization of the
skin. Swiss Med Wkly. 144:w140262014.PubMed/NCBI
|
|
54
|
Passos SK, de Souza PE, Soares PK, Eid DR,
Primo FL, Tedesco AC, Lacava ZG and Morais PC: Quantitative
approach to skin field cancerization using a nanoencapsulated
photodynamic therapy agent: A pilot study. Clin Cosmet Investig
Dermatol. 6:51–59. 2013.PubMed/NCBI
|
|
55
|
Reinhold U, Dirschka T, Ostendorf R,
Aschoff R, Berking C, Philipp-Dormston WG, Hahn S, Lau K, Jäger A,
Schmitz B, et al: A randomized, double-blind, phase III,
multicentre study to evaluate the safety and efficacy of BF-200 ALA
(Ameluz(®) vs. placebo in the field-directed treatment
of mild-to-moderate actinic keratosis with photodynamic therapy
(PDT) when using the BF-RhodoLED(®) lamp. Br J Dermatol.
175:696–705. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Genovese G, Fai D, Fai C, Mavilia L and
Mercuri SR: Daylight methyl-aminolevulinate photodynamic therapy
versus ingenol mebutate for the treatment of actinic keratoses: An
intraindividual comparative analysis. Dermatol Ther (Heidelb).
29:191–196. 2016. View Article : Google Scholar
|
|
57
|
Sotiriou E, Apalla Z, Vrani F, Lallas A,
Chovarda E and Ioannides D: Photodynamic therapy vs. imiquimod 5%
cream as skin cancer preventive strategies in patients with field
changes: A randomized intraindividual comparison study. J Eur Acad
Dermatol Venereol. 29:325–329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Holzer G, Pinkowicz A, Radakovic S,
Schmidt JB and Tanew A: Randomized controlled trial comparing 35%
trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic
therapy for treating multiple actinic keratosis. Br J Dermatol.
176:1155–1161. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Torezan L, Chaves Y, Niwa A, Sanches JA
Jr, Festa-Neto C and Szeimies RM: A pilot split-face study
comparing conventional methyl aminolevulinate-photodynamic therapy
(PDT) with microneedling-assisted PDT on actinically damaged skin.
Dermatol Surg. 39:1197–1201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
See JA, Shumack S, Murrell DF, Rubel DM,
Fernández-Peñas P, Salmon R, Hewitt D, Foley P and Spelman L:
Consensus recommendations on the use of daylight photodynamic
therapy with methyl aminolevulinate cream for actinic keratoses in
Australia. Australas J Dermatol. 57:167–174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wiegell SR, Haedersdal M, Philipsen PA,
Eriksen P, Enk CD and Wulf HC: Continuous activation of PpIX by
daylight is as effective as and less painful than conventional
photodynamic therapy for actinic keratoses; a randomized,
controlled, single-blinded study. Br J Dermatol. 158:740–746. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Griffin LL and Lear JT: Photodynamic
therapy and non-melanoma skin cancer. Cancers (Basel). 8:982016.
View Article : Google Scholar
|
|
63
|
Lacour JP, Ulrich C, Gilaberte Y, Von
Felbert V, Basset-Seguin N, Dreno B, Girard C, Redondo P,
Serra-Guillen C, Synnerstad I, et al: Daylight photodynamic therapy
with methyl aminolevulinate cream is effective and nearly painless
in treating actinic keratoses: A randomised, investigator-blinded,
controlled, phase III study throughout Europe. J Eur Acad Dermatol
Venereol. 29:2342–2348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fargnoli MC, Piccioni A, Neri L, Tambone
S, Pellegrini C and Peris K: Conventional vs. daylight methyl
aminolevulinate photodynamic therapy for actinic keratosis of the
face and scalp: An intra-patient, prospective, comparison study in
Italy. J Eur Acad Dermatol Venereol. 29:1926–1932. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cantisani C, Paolino G, Bottoni U and
Calvieri S: Daylight-photodynamic therapy for the treatment of
actinic keratosis in different seasons. J Drugs Dermatol.
14:1349–1353. 2015.PubMed/NCBI
|
|
66
|
Sotiriou E, Apalla Z, Vrani F, Lazaridou
E, Vakirlis E, Lallas A and Ioannides D: Daylight photodynamic
therapy vs. conventional photodynamic therapy as skin cancer
preventive treatment in patients with face and scalp cancerization:
An intra-individual comparison study. J Eur Acad Dermatol Venereol.
31:1303–1307. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sotiriou E, Evangelou G, Papadavid E,
Apalla Z, Vrani F, Vakirlis E, Panagiotou M, Stefanidou M, Pombou
T, Krasagakis K, et al: Conventional vs. daylight photodynamic
therapy for patients with actinic keratosis on face and scalp:
12-month follow-up results of a randomized, intra-individual
comparative analysis. J Eur Acad Dermatol Venereol. 32:595–600.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Neittaanmäki-Perttu N, Karppinen TT,
Grönroos M, Tani TT and Snellman E: Daylight photodynamic therapy
for actinic keratoses: A randomized double-blinded nonsponsored
prospective study comparing 5-aminolaevulinic acid nanoemulsion
(BF-200) with methyl-5-aminolaevulinate. Br J Dermatol.
171:1172–1180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Neittaanmäki-Perttu N, Grönroos M, Tani T
and Snellman E: Long-term outcome of daylight photodynamic therapy
with amino-5-laevulinate nanoemulsion vs. methyl-5-aminolaevulinate
for actinic keratoses. Acta Derm Venereol. 96:712–713. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Neittaanmäki-Perttu N, Karppinen TT, Tani
T, Snellman E and Grönroos M: Long-term outcome of
low-concentration Hexyl-5-aminolaevulinate daylight photodynamic
therapy for treatment of actinic keratoses. Acta Derm Venereol.
97:120–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Calzavara-Pinton P, Zane C, Pacou M and
Szeimies RM: Bucher's indirect comparison of daylight photodynamic
therapy with methyl aminolevulinate cream versus diclofenac plus
hyaluronic acid gel for the treatment of multiple actinic
keratosis. Eur J Dermatol. 26:487–492. 2016.PubMed/NCBI
|
|
72
|
Moggio E, Arisi M, Zane C,
Calzavara-Pinton I and Calzavara-Pinton P: A randomized split-face
clinical trial analyzing daylight photodynamic therapy with methyl
aminolaevulinate vs ingenol mebutate gel for the treatment of
multiple actinic keratoses of the face and the scalp. Photodiagn
Photodyn Ther. 16:161–165. 2016. View Article : Google Scholar
|
|
73
|
Galimberti GN: Calcipotriol as
pretreatment prior to daylight-mediated photodynamic therapy in
patients with actinic keratosis: A case series. Photodiagn Photodyn
Ther. 21:172–175. 2018. View Article : Google Scholar
|
|
74
|
Nissen CV, Heerfordt IM, Wiegell SR,
Mikkelsen CS and Wulf HC: Pretreatment with 5-fluorouracil cream
enhances the efficacy of daylight-mediated photodynamic therapy for
actinic keratosis. Acta Derm Venereol. 97:617–621. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Spelman L, Rubel D, Murrell DF, See JA,
Hewitt D, Foley P, Salmon R, Kerob D, Pascual T, Shumack S, et al:
Treatment of face and scalp solar (actinic) keratosis with
daylight-mediated photodynamic therapy is possible throughout the
year in Australia: Evidence from a clinical and meteorological
study. Australas J Dermatol. 57:24–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
O'Gorman SM, Clowry J, Manley M, McCavana
J, Gray L, Kavanagh A, Lally A and Collins P: Artificial white
light vs daylight photodynamic therapy for actinic keratoses: A
randomized clinical trial. JAMA Dermatol. 152:638–644. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Diaconeasa A, Boda D, Neagu M, Constantin
C, Căruntu C, Vlădău L and Guţu D: The role of confocal microscopy
in the dermato-oncology practice. J Med Life. 4:63–74.
2011.PubMed/NCBI
|
|
78
|
Seyed Jafari SM, Timchik T and Hunger RE:
In vivo confocal microscopy efficacy assessment of daylight
photodynamic therapy in actinic keratosis patients. Br J Dermatol.
175:375–381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
de Souza ALR, LaRochelle E, Marra K, Gunn
J, Davis SC, Samkoe KS, Chapman MS, Maytin EV, Hasan T and Pogue
BW: Assessing daylight & low-dose rate photodynamic therapy
efficacy, using biomarkers of photophysical, biochemical and
biological damage metrics in situ. Photodiagn Photodyn Ther.
20:227–233. 2017. View Article : Google Scholar
|
|
80
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, et al: Neuroendocrine factors: The missing link in non-melanoma
skin cancer (Review). Oncol Rep. 38:1327–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues (Review).
Int J Oncol. 52:637–655. 2018.PubMed/NCBI
|
|
82
|
Dinu LU, Ene CD, Nicolae IL, Tampa M,
Matei CL and Georgescu SR: The serum levels of
8-hidroxy-deoxyguanosine under the chemicals influence. Rev Chim.
65:1319–1326. 2014.
|
|
83
|
Nicolae I, Tampa M, Mitran C, Ene CD,
Mitran M, Matei C, Musetescu A, Pituru S, Pop CS and Georgescu SR:
Gamma-glutamyl transpeptidase alteration as a biomarker of
oxidative stress in patients with human papillomavirus lesions
following topical treatment with sinecatechins. Farmacia.
65:617–623. 2017.
|
|
84
|
Lucena SR, Salazar N, Gracia-Cazaña T,
Zamarrón A, González S, Juarranz Á and Gilaberte Y: Combined
treatments with photodynamic therapy for non-melanoma skin cancer.
Int J Mol Sci. 16:25912–25933. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Victoria-Martínez AM, Martínez-Leborans L,
Ortiz-Salvador JM and Pérez-Ferriols A: Treatment of Bowen disease
with photodynamic therapy and the advantages of sequential topical
imiquimod. Actas Dermosifiliogr. 108:e9–e14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kim SK, Park JY, Song HS, Kim YS and Kim
YC: Photodynamic therapy with ablative carbon dioxide fractional
laser for treating Bowen disease. Ann Dermatol. 25:335–339. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Sung JM and Kim YC: Photodynamic therapy
with epidermal ablation using fractional carbon-dioxide laser in
the treatment of Bowen's disease: A case series. Photodiagn
Photodyn Ther. 19:84–85. 2017. View Article : Google Scholar
|
|
88
|
Ko DY, Kim KH and Song KH: A randomized
trial comparing methyl aminolaevulinate photodynamic therapy with
and without Er:YAG ablative fractional laser treatment in Asian
patients with lower extremity Bowen disease: results from a
12-month follow-up. Br J Dermatol. 170:165–172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Park JY, Kim SK, Cho KH and Kim YC: Huge
Bowen's disease: A pitfall of topical photodynamic therapy.
Photodiagn Photodyn Ther. 10:546–548. 2013. View Article : Google Scholar
|
|
90
|
Skroza N, LA Viola G, Pampena R, Proietti
I, Bernardini N, Tolino E, Annetta A, Zuber S, Balduzzi V and
Potenza C: Erythroplasia of Queyrat treated with methyl
aminolevulinate-photodynamic therapy (MAL-PDT): Case report and
review of the literature. G Ital Dermatol Venereol. Dec
1–2016.(Epub ahead of print).
|
|
91
|
Maranda EL, Nguyen AH, Lim VM, Shah VV and
Jimenez JJ: Erythroplasia of Queyrat treated by laser and light
modalities: A systematic review. Lasers Med Sci. 31:1971–1976.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yazdani Abyaneh MA, Falto-Aizpurua L,
Griffith RD and Nouri K: Photodynamic therapy for actinic
cheilitis: A systematic review. Dermatol Surg. 41:189–198. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Radakovic S and Tanew A: 5-aminolaevulinic
acid patch-photodynamic therapy in the treatment of actinic
cheilitis. Photodermatol Photoimmunol Photomed. 33:306–310. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Da Costa Fontes KBF, Leite TC, Cunha KSG,
De Oliveira Miranda AM, Issa MCA, Kurachi C and Dias EP: Clinical
and histopathological outcomes of one session of photodynamic
therapy for actinic cheilitis. Oral Surg Oral Med Oral Pathol Oral
Radiol. 117:e2012014. View Article : Google Scholar
|
|
95
|
Chaves YN, Torezan LA, Lourenço SV and
Neto CF: Evaluation of the efficacy of photodynamic therapy for the
treatment of actinic cheilitis. Photodermatol Photoimmunol
Photomed. 33:14–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Fontes KB, Leite TC, Miranda AM, Issa MC,
Dias EP, Kurachi C, da Silva LE and Cunha KG: Clinical and
histopathological outcomes of one session of photodynamic therapy
with previous CO2 laser application for actinic
cheilitis. Photodiagn Photodyn Ther. 12:3382015. View Article : Google Scholar
|
|
97
|
Choi SH, Kim KH and Song KH: Efficacy of
ablative fractional laser-assisted photodynamic therapy for the
treatment of actinic cheilitis: 12-month follow-up results of a
prospective, randomized, comparative trial. Br J Dermatol.
173:184–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Levi A, Wulf HC and Enk CD: Two cases of
actinic cheilitis responsive to daylight-activated photodynamic
therapy (DA-PDT). Photodermatol Photoimmunol Photomed. 29:268–271.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Fai D, Romanello E, Brumana MB, Fai C,
Vena GA, Cassano N and Piaserico S: Daylight photodynamic therapy
with methyl-aminolevulinate for the treatment of actinic cheilitis.
Dermatol Ther (Heidelb). 28:355–368. 2015. View Article : Google Scholar
|
|
100
|
Farias MM, Hasson A, Navarrete C, Nicklas
C, Garcia-Huidobro I and Gonzalez S: Efficacy of topical
photodynamic therapy for keratoacanthomas: A case-series of four
patients. Indian J Dermatol Venereol Leprol. 78:172–174. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Mlacker S, Kaw U and Maytin EV: Use of
photodynamic therapy and acitretin in generalized eruptive
keratoacanthoma of Grzybowski. JAAD Case Rep. 3:457–459. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Maydan E, Nootheti PK and Goldman MP:
Development of a keratoacanthoma after topical photodynamic therapy
with 5-aminolevulinic acid. J Drugs Dermatol. 5:804–806.
2006.PubMed/NCBI
|
|
103
|
Gogia R, Grekin RC and Shinkai K: Eruptive
self-resolving keratoacanthomas developing after treatment with
photodynamic therapy and microdermabrasion. Dermatol Surg.
39:1717–1720. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Halonen P, Jakobsson M, Heikinheimo O,
Riska A, Gissler M and Pukkala E: Lichen sclerosus and risk of
cancer. Int J Cancer. 140:1998–2002. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Kirtschig G, Becker K, Günthert A,
Jasaitiene D, Cooper S, Chi CC, Kreuter A, Rall KK, Aberer W,
Riechardt S, et al: Evidence-based (S3) guideline on (anogenital)
Lichen sclerosus. J Eur Acad Dermatol Venereol. 29:e1–e43. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Shi L, Miao F, Zhang LL, Zhang GL, Wang
PR, Ji J, Wang XJ, Huang Z, Wang HW and Wang XL: Comparison of
5-aminolevulinic acid photodynamic therapy and clobetasol
propionate in treatment of vulvar lichen sclerosus. Acta Derm
Venereol. 96:684–688. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lan T, Zou Y, Hamblin MR and Yin R:
5-Aminolevulinic acid photodynamic therapy in refractory vulvar
lichen sclerosus et atrophicus: Series of ten cases. Photodiagn
Photodyn Ther. 21:234–238. 2018. View Article : Google Scholar
|
|
108
|
Maździarz A, Osuch B, Kowalska M,
Nalewczyńska A and Śpiewankiewicz B: Photodynamic therapy in the
treatment of vulvar lichen sclerosus. Photodiagn Photodyn Ther.
19:135–139. 2017. View Article : Google Scholar
|
|
109
|
Olejek A, Gabriel I, Bilska-Janosik A,
Kozak-Darmas I and Kawczyk-Krupka A: ALA-Photodynamic treatment in
Lichen sclerosus - clinical and immunological outcome focusing on
the assesment of antinuclear antibodies. Photodiagn Photodyn Ther.
18:128–132. 2017. View Article : Google Scholar
|
|
110
|
Criscuolo AA, Schipani C, Cannizzaro MV,
Messinese S, Chimenti S, Piccione E and Saraceno R: New therapeutic
approaches in the treatment of anogenital lichen sclerosus: does
photodynamic therapy represent a novel option? G Ital Dermatol
Venereol. 152:117–121. 2017.PubMed/NCBI
|
|
111
|
Tampa M, Sârbu MI, Mitran MI, Mitran CI,
Dumitru A, Benea V and Georgescu SR: Pain in photodynamic therapy.
J Mind Med Sci. 3:19–30. 2016.
|
|
112
|
Cabete J, Campos S and Lestre S: Conscious
sedation with inhaled 50% nitrous oxide/oxygen premix in
photodynamic therapy sessions for vulvar lichen sclerosus
treatment. An Bras Dermatol. 90:120–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Osiecka BJ, Jurczyszyn K, Nockowski P,
Murawski M and Ziółkowski P: Photodynamic therapy with green light
for the treatment of vulvar lichen sclerosus - preliminary results.
Photodiagn Photodyn Ther. 17:185–187. 2017. View Article : Google Scholar
|
|
114
|
Mercuri SR, Brianti P, Foti A, Bartolucci
M, Dattola A and Nisticò SP: Penile lichen sclerosus treated with
1927 nm thulium fiber laser and photodynamic therapy: A new
possible therapeutic approach. Photomed Laser Surg. 36:333–336.
2018. View Article : Google Scholar : PubMed/NCBI
|
